Multiple Myeloma — Trials

Multiple Myeloma — Trials · CancerIndex

Clinical trials

Registered studies

3,384 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 814
Recruiting: 414
Ph III recruiting: 54
Growth YoY: +13.3%
Industry share: 29%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%
Trials / 1,000 deaths: 70.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (537)

clinicaltrialsPublishedShowing 51–68 of 68 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06487247	HEME Home Transfusion Program	recruiting	N/A	700	Dana-Farber Cancer InstituteOTHER	1	Sep 17, 2025	clinicaltrials
NCT06133426	Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients(BTP)	recruiting	N/A	30	Assistance Publique - Hôpitaux de ParisOTHER	1	Sep 15, 2025	clinicaltrials